Ambrx Biopharma, Inc.
AMAMDelisted Mar 7, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001990550
Ambrx Biopharma, Inc. was delisted on Mar 7, 2024; its insiders filed their last Form 4 on Mar 7, 2024; 68 institutions reported holding it in 13F filings for Q4 2023, worth $912.7M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Ambrx Biopharma, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +12 vs. Q1 2023
- Shares held
- 47.9M
- +10.8M (+29.3%) vs. Q1 2023
- Total value
- $788.8M
- +$458.1M (+138.5%) vs. Q1 2023
- New holders
- 18
- 13 more added
- Sold out
- 6
- 8 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AMAM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 68 | $912.7M |
| Q3 2023 | 44 | $568.3M |
| Q2 2023 | 42 | $788.8M |
| Q1 2023 | 30 | $330.7M |
| Q4 2022 | 18 | $40.7M |
| Q3 2022 | 16 | $18.0M |
| Q2 2022 | 14 | $45.4M |
| Q1 2022 | 14 | $70.6M |
| Q4 2021 | 16 | $152.0M |
| Q3 2021 | 15 | $165.3M |
| Q2 2021 | 20 | $266.2M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Ambrx Biopharma, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Darwin Global Management, Ltd. | 16,688,636 | $274.7M | 44.91% | +5,384,063+47.6% | Added |
| Cormorant Asset Management, LP | 9,616,155 | $158.3M | 9.01% | +1,116,155+13.1% | Added |
| D. E. Shaw & Co., Inc. | 4,015,908 | $66.1M | 0.10% | +82,356+2.1% | Added |
| Commodore Capital LP | 3,175,000 | $52.3M | 5.87% | −1,628,447−33.9% | Reduced |
| VR Adviser, LLC | 2,484,960 | $40.9M | 6.54% | −813,617−24.7% | Reduced |
| Farallon Capital Management, L.L.C. | 2,269,000 | $37.3M | 0.22% | +1,908,000+528.5% | Added |
| FMR LLC | 2,210,618 | $36.4M | 0.00% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 1,650,499 | $27.2M | 2.20% | +1,650,499 | New |
| Price T Rowe Associates Inc | 929,317 | $15.3M | 0.00% | +718,690+341.2% | Added |
| Holocene Advisors, LP | 913,754 | $15.0M | 0.07% | +913,754 | New |
| Citadel Advisors LLC | 727,022 | $12.0M | 0.01% | +19,889+2.8% | Added |
| Artal Group S.A. | 702,291 | $11.6M | 0.37% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 477,558 | $7.86M | 0.09% | +458,061+2,349.4% | Added |
| Point72 Asset Management, L.P. | 349,938 | $5.76M | 0.02% | +349,938 | New |
| Millennium Management LLC | 285,716 | $4.70M | 0.00% | +274,727+2,500.0% | Added |
| Ghost Tree Capital, LLC | 238,225 | $3.92M | 1.42% | −11,775−4.7% | Reduced |
| JPMorgan Chase & Co | 157,858 | $2.60M | 0.00% | +157,858 | New |
| HighVista Strategies LLC | 153,431 | $2.53M | 1.16% | +153,431 | New |
| Moore Capital Management, LP | 144,400 | $2.38M | 0.06% | +144,400 | New |
| First Manhattan Co | 135,003 | $2.22M | 0.01% | +135,003 | New |
| Silverarc Capital Management, LLC | 100,000 | $1.65M | 0.56% | +100,000 | New |
| Schonfeld Strategic Advisors LLC | 98,600 | $1.62M | 0.01% | +20,400+26.1% | Added |
| TD Asset Management Inc | 63,728 | $1.05M | 0.00% | +49,828+358.5% | Added |
| Manufacturers Life Insurance Company, The | 59,197 | $973.8K | 0.00% | +29,674+100.5% | Added |
| Susquehanna International Group, LLP | 51,290 | $844.2K | 0.00% | −30,156−37.0% | Reduced |
| Alps Advisors Inc | 40,598 | $668.2K | 0.01% | +40,598 | New |
| Geode Capital Management, LLC | 39,438 | $649.1K | 0.00% | +39,438 | New |
| Apis Capital Advisors, LLC | 34,000 | $559.6K | 0.56% | +34,000 | New |
| Jane Street Group, LLC | 17,538 | $288.7K | 0.00% | +17,538 | New |
| Innovis Asset Management LLC | 16,826 | $277.0K | 0.10% | +16,826 | New |
| Squarepoint Ops LLC | 16,480 | $271.3K | 0.00% | −1,031−5.9% | Reduced |
| Belvedere Trading LLC | 13,872 | $228.3K | 0.07% | −2,936−17.5% | Reduced |
| QP Wealth Management, LLC | 12,670 | $208.5K | 0.33% | +12,670 | New |
| Exchange Traded Concepts, LLC | 9,830 | $161.7K | 0.00% | +9,830 | New |
| Virtus ETF Advisers LLC | 7,468 | $122.9K | 0.07% | +7,468 | New |
| Simplex Trading, LLC | 6,634 | $109.0K | 0.00% | −113,570−94.5% | Reduced |
| Morgan Stanley | 3,070 | $50.5K | 0.00% | +3,028+7,209.5% | Added |
| Cutler Group LP | 1,800 | $29.0K | 0.01% | −1,300−41.9% | Reduced |
| US Bancorp | 1,018 | $16.8K | 0.00% | +1,018 | New |
| Bank of America Corp | 558 | $9.19K | 0.00% | +454+436.5% | Added |
| Aquatic Capital Management LLC | 400 | $7.00K | 0.00% | +400 | New |
| BerganKDV Wealth Management, LLC | 100 | $1.65K | 0.00% | 00.0% | Unchanged |
| Fosun International Ltd | 0 | $0 | 0.00% | −249,190−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −57,268−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −56,868−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −20,440−100.0% | Sold out |
| Tocqueville Asset Management L.P. | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −3,345−100.0% | Sold out |